Global Injectable Bone Substitute Market

Injectable Bone Substitute Comprehensive Study by Type (Natural Injectable Bone Substitute, Synthetic Injectable Bone Substitute), Application (Hospital, Clinic) Players and Region - Global Market Outlook to 2027

Injectable Bone Substitute Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Injectable Bone Substitute Market Overview:
The injectable bone substitute refers to a synthetic, biologically organic, or inorganic combination which is inserted for the treatment of bone defects. The ideal bone substitute material should exhibit several important properties are biocompatibility, durability, vascularity and angiogenesis, bio-absorbability, cost efficiency, and availability. Market players in the injectable bone substitute market are focusing on the technological advancement in the bone substitute materials. For instance, Stryker provides an injectable bone substitute composed of tetra-calcium phosphate which offers osteointegrative and osteoconductive properties. Further, growing demand from the developing economies expected to drive the demand for injectable bone substitutes over the forecasted period

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Historical Period2017-2021
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Growth Drivers
  • Growing Number of Patients with Orthopedic Disorders
  • Increasing Geriatric Population

Roadblocks
  • Lack of Skilled Healthcare Professionals
  • Stringent Government Regulations Regarding Injectable Bone Substitute

Opportunities
  • Increasing Prevalence of Bone Disorders
  • Growing Healthcare Infrastructure in the Developing Economies

Challenges
  • Lak of Awareness in the Emerging Economies


Competitive Landscape:
Market players are focusing on partnerships, collaborations, and new product launches in order to increase their offerings in the global injectable bone substitute market. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product offerings.
Some of the key players profiled in the report are Wright Medical (United States), Zimmer Biomet (United States), Medtronic (United States), SeaSpine (United States), Johnson & Johnson (United States), Stryker (United States), Xtant Medical (United States), Graftys (France), Arthrex (United States) and Biomatlante (France). Additionally, following companies can also be profiled that are part of our coverage like Biocomposites (United Kingdom) and ORD (Taiwan). Analyst at AMA Research see United States Players to retain maximum share of Global Injectable Bone Substitute market by 2027.

“Acceding to the National Center for Biotechnology Information (NCBI), most injectable bone substitutes belong to one of two major groups: by far the largest group contains products based on various calcium phosphate (CP) mixtures, whilst the smaller group consists of calcium sulfate (CS) compounds.”

What Can be Explored with the Injectable Bone Substitute Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Injectable Bone Substitute Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Injectable Bone Substitute
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Injectable Bone Substitute market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Injectable Bone Substitute market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Injectable Bone Substitute Providers, Research and Development Institutes, Potential Investors, Nationalized Laboratory, Government and Research Organizations, Research Organizations, and Consulting Firms and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Natural Injectable Bone Substitute
  • Synthetic Injectable Bone Substitute
By Application
  • Hospital
  • Clinic
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Spain
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Number of Patients with Orthopedic Disorders
      • 3.2.2. Increasing Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Lak of Awareness in the Emerging Economies
    • 3.4. Market Trends
      • 3.4.1. Technological Advancement in the Bone Substitute Technology
      • 3.4.2. Emphasizing on Development of Novel Material for Bone Substitute
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Injectable Bone Substitute, by Type, Application and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Injectable Bone Substitute (Value)
      • 5.2.1. Global Injectable Bone Substitute by: Type (Value)
        • 5.2.1.1. Natural Injectable Bone Substitute
        • 5.2.1.2. Synthetic Injectable Bone Substitute
      • 5.2.2. Global Injectable Bone Substitute by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Clinic
      • 5.2.3. Global Injectable Bone Substitute Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Spain
          • 5.2.3.3.2. Germany
          • 5.2.3.3.3. France
          • 5.2.3.3.4. Italy
          • 5.2.3.3.5. United Kingdom
          • 5.2.3.3.6. Netherlands
          • 5.2.3.3.7. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Injectable Bone Substitute (Price)
      • 5.3.1. Global Injectable Bone Substitute by: Type (Price)
  • 6. Injectable Bone Substitute: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Wright Medical (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Zimmer Biomet (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medtronic (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. SeaSpine (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Johnson & Johnson (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Stryker (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Xtant Medical (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Graftys (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Arthrex (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Biomatlante (France)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Injectable Bone Substitute Sale, by Type, Application and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Injectable Bone Substitute (Value)
      • 7.2.1. Global Injectable Bone Substitute by: Type (Value)
        • 7.2.1.1. Natural Injectable Bone Substitute
        • 7.2.1.2. Synthetic Injectable Bone Substitute
      • 7.2.2. Global Injectable Bone Substitute by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Clinic
      • 7.2.3. Global Injectable Bone Substitute Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Spain
          • 7.2.3.3.2. Germany
          • 7.2.3.3.3. France
          • 7.2.3.3.4. Italy
          • 7.2.3.3.5. United Kingdom
          • 7.2.3.3.6. Netherlands
          • 7.2.3.3.7. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Injectable Bone Substitute (Price)
      • 7.3.1. Global Injectable Bone Substitute by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Injectable Bone Substitute: by Type(USD Million)
  • Table 2. Injectable Bone Substitute Natural Injectable Bone Substitute , by Region USD Million (2016-2021)
  • Table 3. Injectable Bone Substitute Synthetic Injectable Bone Substitute , by Region USD Million (2016-2021)
  • Table 4. Injectable Bone Substitute: by Application(USD Million)
  • Table 5. Injectable Bone Substitute Hospital , by Region USD Million (2016-2021)
  • Table 6. Injectable Bone Substitute Clinic , by Region USD Million (2016-2021)
  • Table 7. South America Injectable Bone Substitute, by Country USD Million (2016-2021)
  • Table 8. South America Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 9. South America Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 10. Brazil Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 11. Brazil Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 12. Argentina Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 13. Argentina Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 14. Rest of South America Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 15. Rest of South America Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 16. Asia Pacific Injectable Bone Substitute, by Country USD Million (2016-2021)
  • Table 17. Asia Pacific Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 18. Asia Pacific Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 19. China Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 20. China Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 21. Japan Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 22. Japan Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 23. India Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 24. India Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 25. South Korea Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 26. South Korea Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 27. Taiwan Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 28. Taiwan Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 29. Australia Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 30. Australia Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 31. Rest of Asia-Pacific Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 32. Rest of Asia-Pacific Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 33. Europe Injectable Bone Substitute, by Country USD Million (2016-2021)
  • Table 34. Europe Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 35. Europe Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 36. Spain Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 37. Spain Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 38. Germany Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 39. Germany Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 40. France Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 41. France Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 42. Italy Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 43. Italy Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 44. United Kingdom Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 45. United Kingdom Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 46. Netherlands Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 47. Netherlands Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 48. Rest of Europe Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 49. Rest of Europe Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 50. MEA Injectable Bone Substitute, by Country USD Million (2016-2021)
  • Table 51. MEA Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 52. MEA Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 53. Middle East Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 54. Middle East Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 55. Africa Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 56. Africa Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 57. North America Injectable Bone Substitute, by Country USD Million (2016-2021)
  • Table 58. North America Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 59. North America Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 60. United States Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 61. United States Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 62. Canada Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 63. Canada Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 64. Mexico Injectable Bone Substitute, by Type USD Million (2016-2021)
  • Table 65. Mexico Injectable Bone Substitute, by Application USD Million (2016-2021)
  • Table 66. Injectable Bone Substitute: by Type(USD/Units)
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Injectable Bone Substitute: by Type(USD Million)
  • Table 78. Injectable Bone Substitute Natural Injectable Bone Substitute , by Region USD Million (2022-2027)
  • Table 79. Injectable Bone Substitute Synthetic Injectable Bone Substitute , by Region USD Million (2022-2027)
  • Table 80. Injectable Bone Substitute: by Application(USD Million)
  • Table 81. Injectable Bone Substitute Hospital , by Region USD Million (2022-2027)
  • Table 82. Injectable Bone Substitute Clinic , by Region USD Million (2022-2027)
  • Table 83. South America Injectable Bone Substitute, by Country USD Million (2022-2027)
  • Table 84. South America Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 85. South America Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 86. Brazil Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 87. Brazil Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 88. Argentina Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 89. Argentina Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 90. Rest of South America Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 91. Rest of South America Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 92. Asia Pacific Injectable Bone Substitute, by Country USD Million (2022-2027)
  • Table 93. Asia Pacific Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 94. Asia Pacific Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 95. China Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 96. China Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 97. Japan Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 98. Japan Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 99. India Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 100. India Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 101. South Korea Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 102. South Korea Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 103. Taiwan Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 104. Taiwan Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 105. Australia Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 106. Australia Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 107. Rest of Asia-Pacific Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 108. Rest of Asia-Pacific Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 109. Europe Injectable Bone Substitute, by Country USD Million (2022-2027)
  • Table 110. Europe Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 111. Europe Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 112. Spain Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 113. Spain Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 114. Germany Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 115. Germany Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 116. France Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 117. France Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 118. Italy Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 119. Italy Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 120. United Kingdom Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 121. United Kingdom Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 122. Netherlands Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 123. Netherlands Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 124. Rest of Europe Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 125. Rest of Europe Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 126. MEA Injectable Bone Substitute, by Country USD Million (2022-2027)
  • Table 127. MEA Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 128. MEA Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 129. Middle East Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 130. Middle East Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 131. Africa Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 132. Africa Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 133. North America Injectable Bone Substitute, by Country USD Million (2022-2027)
  • Table 134. North America Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 135. North America Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 136. United States Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 137. United States Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 138. Canada Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 139. Canada Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 140. Mexico Injectable Bone Substitute, by Type USD Million (2022-2027)
  • Table 141. Mexico Injectable Bone Substitute, by Application USD Million (2022-2027)
  • Table 142. Injectable Bone Substitute: by Type(USD/Units)
  • Table 143. Research Programs/Design for This Report
  • Table 144. Key Data Information from Secondary Sources
  • Table 145. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Injectable Bone Substitute: by Type USD Million (2016-2021)
  • Figure 5. Global Injectable Bone Substitute: by Application USD Million (2016-2021)
  • Figure 6. South America Injectable Bone Substitute Share (%), by Country
  • Figure 7. Asia Pacific Injectable Bone Substitute Share (%), by Country
  • Figure 8. Europe Injectable Bone Substitute Share (%), by Country
  • Figure 9. MEA Injectable Bone Substitute Share (%), by Country
  • Figure 10. North America Injectable Bone Substitute Share (%), by Country
  • Figure 11. Global Injectable Bone Substitute: by Type USD/Units (2016-2021)
  • Figure 12. Global Injectable Bone Substitute share by Players 2021 (%)
  • Figure 13. Global Injectable Bone Substitute share by Players (Top 3) 2021(%)
  • Figure 14. Global Injectable Bone Substitute share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Wright Medical (United States) Revenue, Net Income and Gross profit
  • Figure 17. Wright Medical (United States) Revenue: by Geography 2021
  • Figure 18. Zimmer Biomet (United States) Revenue, Net Income and Gross profit
  • Figure 19. Zimmer Biomet (United States) Revenue: by Geography 2021
  • Figure 20. Medtronic (United States) Revenue, Net Income and Gross profit
  • Figure 21. Medtronic (United States) Revenue: by Geography 2021
  • Figure 22. SeaSpine (United States) Revenue, Net Income and Gross profit
  • Figure 23. SeaSpine (United States) Revenue: by Geography 2021
  • Figure 24. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 25. Johnson & Johnson (United States) Revenue: by Geography 2021
  • Figure 26. Stryker (United States) Revenue, Net Income and Gross profit
  • Figure 27. Stryker (United States) Revenue: by Geography 2021
  • Figure 28. Xtant Medical (United States) Revenue, Net Income and Gross profit
  • Figure 29. Xtant Medical (United States) Revenue: by Geography 2021
  • Figure 30. Graftys (France) Revenue, Net Income and Gross profit
  • Figure 31. Graftys (France) Revenue: by Geography 2021
  • Figure 32. Arthrex (United States) Revenue, Net Income and Gross profit
  • Figure 33. Arthrex (United States) Revenue: by Geography 2021
  • Figure 34. Biomatlante (France) Revenue, Net Income and Gross profit
  • Figure 35. Biomatlante (France) Revenue: by Geography 2021
  • Figure 36. Global Injectable Bone Substitute: by Type USD Million (2022-2027)
  • Figure 37. Global Injectable Bone Substitute: by Application USD Million (2022-2027)
  • Figure 38. South America Injectable Bone Substitute Share (%), by Country
  • Figure 39. Asia Pacific Injectable Bone Substitute Share (%), by Country
  • Figure 40. Europe Injectable Bone Substitute Share (%), by Country
  • Figure 41. MEA Injectable Bone Substitute Share (%), by Country
  • Figure 42. North America Injectable Bone Substitute Share (%), by Country
  • Figure 43. Global Injectable Bone Substitute: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Wright Medical (United States)
  • Zimmer Biomet (United States)
  • Medtronic (United States)
  • SeaSpine (United States)
  • Johnson & Johnson (United States)
  • Stryker (United States)
  • Xtant Medical (United States)
  • Graftys (France)
  • Arthrex (United States)
  • Biomatlante (France)
Additional players considered in the study are as follows:
Biocomposites (United Kingdom) , ORD (Taiwan)
Select User Access Type

Key Highlights of Report


Jul 2022 176 Pages 60 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Injectable Bone Substitute Market Quantitative research analysis
Global Injectable Bone Substitute Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Injectable Bone Substitute market are Wright Medical (United States), Zimmer Biomet (United States), Medtronic (United States), SeaSpine (United States), Johnson & Johnson (United States), Stryker (United States), Xtant Medical (United States), Graftys (France), Arthrex (United States) and Biomatlante (France), to name a few.
"Technological Advancement in the Bone Substitute Technology " is seen as one of major influencing trends for Injectable Bone Substitute Market during projected period 2021-2027.
Natural Injectable Bone Substitute segment in Global market to hold robust market share owing to "Growing Number of Patients with Orthopedic Disorders ".
Hospitals dominated the Injectable Bone Substitute market. This is attributable due to "Growing Number of Patients with Orthopedic Disorders "
Natural Injectable Bone Substitute dominated the Injectable Bone Substitute market. This is attributable to growing trend of "Technological Advancement in the Bone Substitute Technology "

Know More About Global Injectable Bone Substitute Market Report?

Have a Query? Click Here

Other Related Reports

Digital Healthcare Comprehensive Study by Application (Patients, Healthcare Providers, Pharmaceutical Companies, Others), Services (Monitoring Services, Independent Aging Solutions, Diagnosis Service...
$ 3750
Cephalometric Radiograph Comprehensive Study by Type (Digital X-ray Systems, Analog X-ray Systems), Application (Diagnostic, Therapeutic, Cosmetic, Forensic), End-User (Dental Hospitals and Clinics, ...
$ 3450
4D Printing in Healthcare Comprehensive Study by Type (Fused Deposition Modelling (FDM), PolyJet, Stereolithography, Others), Application (Medical Models, Patient-Specific Implants, Surgical Guides),...
$ 3750
Infusion Pump Software Comprehensive Study by Type (Clinical Workflow, Dose-error reduction software (DERS), Infusion rate calculating software, Others), Application (Pediatrics and Neonatology, Anti...
$ 3650
Intraoral Imaging System Comprehensive Study by Type (2D Imaging system, 3D Imaging System), Application (Diagnostic Applications, Therapeutic Applications, Cosmetic Applications, Forensic Applicatio...
$ 3750
Smart Diabetes Management Comprehensive Study by Type (Smart Glucose Meters, Continuous Glucose Monitoring Systems, Smart Insulin Pens, Smart Insulin Pumps, Closed-Loop Systems, Apps & Software), App...
$ 3650